Summaries for Ollier Disease

Sources:
6Disease Ontology, 30NIH Rare Diseases, 17Genetics Home Reference, 44Wikipedia, 22MalaCards
See all sources

Export this MalaCard
NIH Rare Diseases: Maffucci syndrome is a disorder that primarily affects the bones and skin. It is characterized by multiple enchondromas (benign enlargements of cartilage), bone deformities, and hemangiomas (tangles of abnormal of blood vessels). The abnormal growths associated with Maffucci syndrome may become cancerous (malignant). In particular, affected individuals may develop bone cancers called chondrosarcomas, especially in the skull. They also have an increased risk of other cancers, such as ovarian or liver cancer. The underlying cause of Maffucci syndrome is unknown. No specific genes related to this disorder have been identified. Researchers suggest that the condition may be associated with abnormalities occurring before birth in the development of two embryonic cell layers called the ectoderm and the mesoderm.30

MalaCards: Ollier Disease, also known as maffucci syndrome, is related to hereditary multiple exostoses and spindle cell hemangioma. An important gene associated with Ollier Disease is PTH1R (parathyroid hormone 1 receptor), and among its related pathways are Class B/2 (Secretin family receptors) and Development_Hedgehog and PTH signaling pathways in bone and cartilage development. The drugs interferon alfa-2a,recombinant and interferon alfa-2a and the compounds Isocitric Acid and h2o2 have been mentioned in the context of this disorder. Affiliated tissues include skeletal muscle, liver and skin, and related mouse phenotypes are respiratory system and endocrine/exocrine gland.

Disease Ontology: A syndrome that is characterized by an asymmetric distribution of cartilagenous tumors, which may lead to skeletal deformities and limb-length discrepancy. this condition primarily affects the long bones and cartilage of the joints of the arms and legs, specifically the area where the shaft and head of a long bone meet.6

Genetics Home Reference: Maffucci syndrome is a disorder that primarily affects the bones and skin. It is characterized by multiple enchondromas, which are noncancerous (benign) growths of cartilage that develop on the bones. These growths most commonly occur in the limb bones, especially in the hands and feet; however, they may also occur in the skull, ribs, and vertebrae. Enchondromas may result in severe bone deformities, shortening of the limbs, and fractures. They develop near the ends of bones, where growth occurs, and enchondromas stop forming after affected individuals stop growing. As a result of the bone deformities associated with Maffucci syndrome, people with this disorder generally have short stature and underdeveloped muscles.17

Wikipedia: Ollier disease is a rare nonhereditary sporadic disorder where intraosseous benign cartilaginous tumors...44 more...

Aliases & Descriptions for Ollier Disease

Sources:
6Disease Ontology, 30NIH Rare Diseases, 16GeneTests, 17Genetics Home Reference, 8DISEASES, 32Novoseek , 43UMLS, 40SNOMED-CT, 27NCIt, 24MeSH, 33OMIM
See all sources

Aliases & Descriptions:

ollier disease 6 30 8
maffucci syndrome 6 30 16 17 43
osteochondromatosis 6 16 43
multiple angiomas and endochondromas 30 17
hemangiomatosis chondrodystrophica 30 17
dyschondroplasia 6 30
kast syndrome 30 17
enchondromatosis with multiple cavernous hemangiomas 30
dyschondroplasia and cavernous hemangioma 17
dyschondrodysplasia with hemangiomas 30
multiple cartilaginous enchondroses 30
enchondromatosis with haemangiomata 6
enchondromatosis with hemangiomata 17
hemangiomata with dyschondroplasia 17
chondrodysplasia with hemangioma 17
enchondromatosis, multiple 6
chondroplasia angiomatosis 17
multiple enchondromatosis 30
enchondromatosis 30
olliers disease 32
kast's syndrome 6
hemangioma 43

External Ids:

NCIt27 C3213

Related Diseases for Ollier Disease

Sources:
13GeneCards, 14GeneDecks
See all sources

Diseases related to ollier disease by text searches and GeneDecks gene sharing:

(show top 50)    (show all 235)
idRelated DiseaseScoreTop Affiliating Genes
1hereditary multiple exostoses31.4EXT2, EXT1
2spindle cell hemangioma29.7IDH2, IDH1
3enchondroma28.7PTPN11, PTHLH, PTH1R, IDH2, IDH1
4enchondromatosis28.4PTHLH, PTH1R, EXT2, EXT1, IHH
5exostoses27.9PTPN11, EXT2, EXT1
6primary hyperparathyroidism26.9PTHLH, PTH1R, CD36
7hepatitis26.1PLAU, CTSB, PTPN11, PTHLH, IDH2, IDH1
8thyroiditis26.1PLAU, CTSB, PTHLH, PTH1R, GNAS, IDH2
9hyperparathyroidism25.8CD36, GNAS, PTH1R, PTHLH
10pheochromocytoma25.1PTHLH, GNAS, IDH2, MMP2, CD36
11cerebritis24.4TDP1, PLAU, CTSB, PTPN11, GNAS, IDH2
12meningioma24.0TDP1, PLAU, CTSB, PTHLH, MMP2, MMP12
13astrocytoma23.3PLAU, CTSB, PTHLH, IDH2, IDH1, MMP2
14lung carcinoma23.3TDP1, PLAU, CTSB, PTPN11, PTHLH, GNAS
15carcinoma22.6TDP1, PLAU, CTSB, PTPN11, PTHLH, PTH1R
16sarcoma22.5PLAU, CTSB, PTPN11, PTHLH, EXT2, EXT1
17jansen's metaphyseal chondrodysplasia13.5PTH1R, PTHLH
18interval angle-closure glaucoma13.5IDH2, IDH1
19metaphyseal chondrodysplasia13.5PTHLH, PTH1R
20d-2-hydroxyglutaric aciduria13.5IDH2, IDH1
21intraductal papilloma13.5IDH2, IDH1
22osteochondrodysplasia13.5PTHLH, PTH1R
23humoral hypercalcemia of malignancy13.5PTHLH, PTH1R
242-hydroxyglutaric aciduria13.4IDH2, IDH1
25clear cell chondrosarcoma13.4PTHLH, CD36
26achondroplasia13.3PTHLH, PTH1R, IHH
27dysplasia epiphysealis hemimelica13.3EXT2, EXT1
28pseudohypoparathyroidism type 1b13.3PTHLH, GNAS
29myeloid malignancy13.1IDH1, IDH2, PTPN11
30pseudohypoparathyroidism type ib13.1GNAS, PTH1R, PTHLH
31chst3-related skeletal dysplasia13.1PTHLH, PTH1R, GNAS
32essential thrombocythemia13.1IDH2, IDH1, CD36
33pseudohypoparathyroidism13.1PTHLH, PTH1R, GNAS
34hypophosphatemia13.0PTHLH, PTH1R, GNAS
35hypoparathyroidism13.0PTHLH, PTH1R, GNAS
36osteofibrous dysplasia13.0GNAS, CD36
37fibromatosis, gingival12.9MMP2, CD36
38brachydactyly12.9PTHLH, GNAS, IHH
39pulmonary sarcoidosis12.9MMP12, PTHLH, CTSB
40chondrodysplasia12.9CD36, PTH1R, PTHLH
41hypocalcemia12.9CD36, GNAS, PTHLH
42fibrous dysplasia12.9CD36, GNAS, PTHLH
43craniosynostosis12.8IHH, GNAS, EXT2
44osteochondroma12.8PTPN11, PTHLH, EXT2, EXT1
45periostitis12.8CTSB, IDH2, IDH1, CD36
46exostosis12.8EXT2, EXT1, IHH, MMP12
47paraganglioma12.7IDH2, IDH1, MMP2
48osteomalacia12.7PTHLH, PTH1R, GNAS, CD36
49gastric cardia adenocarcinoma12.7CTSB, MMP2, MMP12
50chronic kidney failure12.6CTSB, PTHLH, PTH1R, GNAS

Graphical network of the top 20 diseases related to ollier disease:



Graphical network of diseases related to ollier disease

Clinical Features for Ollier Disease

Drugs & Therapeutics for Ollier Disease

Sources:
4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT
See all sources

Genetic Tests for Ollier Disease

Sources:
16GeneTests
See all sources

Genetic tests related to ollier disease:

id Genetic test Affiliating Genes
1 Ollier Disease
clinical/research

Anatomical Context for Ollier Disease

Sources:
22MalaCards
See all sources

MalaCards organs/tissues related to ollier disease:

22
Skeletal muscle, Liver, Skin

Phenotypes for genes affiliated with Ollier Disease

Sources:
25MGI
See all sources

Publications for genes affiliated with Ollier Disease

Sources:
35PubMed
See all sources

Articles related to ollier disease:

idTitleAuthorsYearAffiliating Genes
1Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci sy ndrome. (22057234)Pansuriya T.C.... BovAce J.V.2011IDH1, IDH2
2Loss-of-function mutations in PTPN11 cause metachondr omatosis, but not Ollier disease or Maffucci syndrome. (21533187)Bowen M.E.... Warman M.L.2011PTPN11
3Ollier disease and Maffucci syndrome are caused by so matic mosaic mutations of IDH1 and IDH2. (22057236)Amary M.F.... Flanagan A.M.2011IDH1, IDH2
4PTHR1 mutations associated with Ollier disease result in receptor loss of function. (18559376)Couvineau A.... Silve C.2008GNAS, PTH1R, PTHLH
5Establishment and characterization of the permanent human cell line C3842 derived from a secondary chondrosarcoma in Ollier's disease. (15731924)Kalinski T.... Roessner A.2005MMP2, CTSB, PLAU
6Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C. (15523647)Rozeman L.B.... Bovee J.V.M.G.2004PTH1R

Expression for genes affiliated with Ollier Disease

Sources:
1BioGPS
See all sources
Expression patterns in normal tissues for genes affiliated with Ollier Disease

Pathways for genes affiliated with Ollier Disease

Sources:
38Reactome, 41Thomson Reuters, 10EMD Millipore
See all sources

Compounds for genes affiliated with Ollier Disease

Sources:
9DrugBank, 18HMDB, 32Novoseek , 42Tocris Bioscience, 34PharmGKB
See all sources

Compounds related to ollier disease according to GeneDecks:

(show all 46)
idCompoundScoreTop Affiliating Genes
1Isocitric Acid9 18 9 12.3IDH1, IDH2
2h2o232 10.2PTPN11
322-oxacalcitriol32 10.2CD36, PTHLH
4teriparatide32 9 9 12.1CD36, PTH1R
5calcium carbonate32 10.1PTHLH, CD36
6halofuginone32 10.0CD36, MMP2
7zoledronic acid32 9.8PTHLH, MMP2, CD36
8alendronate32 9 9 11.8PTHLH, MMP2, CD36
9leupeptin32 9.6CTSB, PLAU
10(4-aminophenyl)mercuric acetate32 9.6CD36, MMP2
11octreotide32 42 9 9 12.4PTHLH, GNAS, MMP2
12hydroxyproline32 18 10.4CTSB, PTHLH, MMP2, CD36
13calcitriol32 42 9 18 9 13.2PLAU, PTHLH, PTH1R, CD36
14marimastat32 42 9 9 12.2PLAU, MMP2, MMP12
15aprotinin32 9 9 11.1PLAU, CTSB, MMP2
16ag 147832 9.1MMP2, PTHLH, PTPN11, PLAU
17pge232 9.1GNAS, CTSB, PLAU
18heparan sulfate32 18 10.0EXT1, EXT2, PTHLH, PLAU
19dexamethasone32 42 34 9 9 13.0CTSB, PTPN11, PTHLH, PTH1R, MMP12, CD36
20azathioprine32 34 9 9 12.0PLAU, PTHLH, MMP2
21hydrocortisone32 9 9 10.9CD36, MMP2, PTHLH, PLAU
22tgf beta132 8.9PLAU, PTHLH, MMP2, CD36
23batimastat32 42 9 9 11.9PLAU, MMP2, MMP12, CD36
24herbimycin a32 42 9.8PLAU, PTPN11, MMP2, CD36
25nitric oxide32 9 18 9 11.7CTSB, PTPN11, PTHLH, PTH1R, GNAS, MMP12
26sb 20358032 42 9.7CD36, MMP2, PTPN11, PLAU
27cysteine32 8.6MMP2, CTSB, PLAU
28ribonucleic acid32 8.5PLAU, PTHLH, PTH1R, GNAS, MMP2
29paraffin32 8.5PLAU, CTSB, PTHLH, MMP2, CD36
30heparin32 9 18 9 11.5PLAU, CTSB, PTHLH, EXT1, CD36
31ly29400232 8.4CD36, MMP2, PTPN11, CTSB, PLAU
32creatinine32 8.4PLAU, CTSB, PTHLH, MMP2, CD36
33cycloheximide32 8.4PLAU, CTSB, PTHLH, MMP2, CD36
34thymidine32 18 9.3PLAU, CTSB, PTPN11, PTHLH, PTH1R, GNAS
35glutamine32 8.3PLAU, CTSB, GNAS, IDH1, CD36
36fibrinogen32 8.3PLAU, CTSB, PTPN11, MMP12
37estrogen32 8.1PLAU, CTSB, PTHLH, PTH1R, MMP2, CD36
38retinoic acid32 42 18 10.0PLAU, CTSB, PTHLH, PTH1R, MMP2, CD36
39matrigel32 8.0CD36, PLAU, CTSB, PTHLH, PTH1R, MMP2
40vegf32 7.9PLAU, CTSB, PTPN11, PTHLH, MMP2, MMP12
41glutamate32 7.9PLAU, CTSB, PTPN11, GNAS, IDH1, MMP2
42alanine32 7.8PLAU, CTSB, PTPN11, PTHLH, PTH1R, GNAS
43arginine32 7.8PLAU, CTSB, PTPN11, PTHLH, EXT2, EXT1
44tyrosine32 7.3TDP1, PLAU, CTSB, PTPN11, PTHLH, GNAS
45serine32 7.1PLAU, CTSB, PTPN11, PTHLH, PTH1R, GNAS
46calcium32 9 18 9 9.9PPFIBP1, CTSB, PTPN11, PTHLH, PTH1R, GNAS

GO Terms for genes affiliated with Ollier Disease

Sources:
12Gene Ontology
See all sources

Biological processes related to ollier disease according to GeneDecks:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1glyoxylate cycleGO:00609710.2IDH1, IDH2
2isocitrate metabolic processGO:00610210.0IDH2, IDH1
3cellular polysaccharide biosynthetic processGO:0336929.8EXT1, EXT2
4embryonic skeletal joint developmentGO:0724989.8IHH, EXT1
5heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic processGO:0150149.8EXT1, EXT2
6heparan sulfate proteoglycan biosynthetic processGO:0150129.7EXT1, EXT2
7regulation of cell adhesion mediated by integrinGO:0336289.1PTPN11, PLAU
8proteolysisGO:0065088.0PLAU, CTSB, IHH, MMP2, MMP12

Molecular functions related to ollier disease according to GeneDecks:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1isocitrate dehydrogenase (NADP+) activityGO:00445010.1IDH1, IDH2
2heparan sulfate N-acetylglucosaminyltransferase activityGO:0423289.8EXT1, EXT2
3N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activityGO:0505099.8EXT1, EXT2
4glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activityGO:0505089.7EXT2, EXT1
5transferase activity, transferring glycosyl groupsGO:0167579.7EXT1, EXT2
6peptide hormone receptor bindingGO:0514289.7PTHLH, PTPN11
7acetylglucosaminyltransferase activityGO:0083759.6EXT1, EXT2

Sources for Ollier Disease

2CDC
11FMA
18HMDB
19ICD9CM
20KEGG
24MeSH
25MGI
27NCIt
28NDF-RT
31NINDS
32Novoseek
33OMIM
35PubMed
36QIAGEN
43UMLS